Alnylam upgraded to Peer Perform from Underperform at Wolfe Research

Wolfe Research upgraded Alnylam (ALNY) to Peer Perform from Underperform and removed the firm’s prior $368 price target The company “surprised” with its ability to find new patients, says the analyst, who adds that the stock’s “lofty valuation still bothers us,” but the firm is “owning up to our mistaken Underperform rating,” noting that shares have performed well since November of 2024.